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Abstract
Discovery of most autosomal recessive disease genes has involved analysis of large, often 
consanguineous, multiplex families or small cohorts of unrelated individuals with a well-defined 
clinical condition. Discovery of novel dominant causes of rare, genetically heterogenous 
developmental disorders has been revolutionized by exome analysis of large cohorts of 
phenotypically diverse parent-offspring trios 1,2. Here we analysed 4,125 families with diverse, 
rare, genetically heterogeneous developmental disorders and identified four novel autosomal 
recessive disorders. These four disorders were identified by integrating Mendelian filtering 
(identifying probands with rare biallelic putatively damaging variants in the same gene) with 
statistical assessments of (i) the likelihood of sampling the observed genotypes from the general 
population, and (ii) the phenotypic similarity of patients with the same recessive candidate gene. 
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This new paradigm promises to catalyse discovery of novel recessive disorders, especially those 
with less consistent or nonspecific clinical presentations, and those caused predominantly by 
compound heterozygous genotypes.
We previously noted an exome-wide excess of inherited loss-of-function (LOF) variants in 
1,133 individuals with undiagnosed rare developmental disorders (DD)1 but recessive DDs 
were typically only observed in a single family 3. This N=1 problem for recessive disorders 
has been well-recognised 4. We hypothesized that by increasing sample size we would 
observe recurrent instances of both known and novel recessive disorders.
Here we describe an exome analysis of 4,125 mainly simplex families with severe DDs 
recruited through Clinical Genetics services in the UK and Ireland. Clinical phenotype was 
systematically recorded using the Human Phenotype Ontology (HPO) 5,6. 1,053 of these 
families had plausibly causative de novo mutations in known disease genes (Methods). To 
identify candidate recessive genes in the remaining 3,072 families all rare (minor allele 
frequency, MAF, less than 1%) biallelic (homozygous or compound heterozygous) protein-
altering variants were identified in each proband. We observed 74 candidate recessive genes 
where at least one allele was predicted to be LOF in two or more families.
For four previously weakly implicated (described in one or two families) recessive disorders 
caused by variants in: LARP7 4,7, LINS 4,8, PIGT 9,10, COL25A111 we identified 
additional families in whom the phenotypic similarity was sufficient for us to consider that 
the evidence supporting these new recessive disorders is now compelling (Supplementary 
Table 1). Furthermore, we identified (DEPDC5) or confirmed (COL9A3 12) apparently 
recessive forms of dominant disorders. This phenomenon of rare recessive forms of 
dominant disorders has been described previously 13,14.
To rigorously assess the evidence supporting each candidate recessive gene, we developed a 
statistical approach that integrates the probabilities of sampling the observed genotypes and 
phenotypes by chance (Methods, Figure 1).
We classified protein-altering variants (Methods, Supplementary Figure 1) into two groups 
of predicted functional consequences: LOF and ‘ functional’  (i.e. protein-altering but not 
likely LOF, e.g. missense). The probability of drawing N unrelated families with similar 
biallelic genotypes by chance from the general population, was estimated as the probability 
of sampling two rare alleles by chance N times from 3,072 random draws using Hardy-
Weinberg rules for estimating expected genotype frequencies from allele frequencies 
(Methods). We estimated this probability separately for two classes of recessive genotype: 
biallelic LOF and compound heterozygous LOF/functional. First we calculated the 
cumulative frequency of rare LOF and missense variants using the Exome Aggregation 
Consortium dataset. The gene-specific cumulative allele frequencies from the ExAC dataset 
(European, non-Finnish, ancestry) were highly concordant with the frequencies from 
unaffected parents (of European ancestry) (Supplementary Figure 2), showing that the 
datasets are comparable. Our method corrects for gene-specific levels of autozygosity 
(Supplementary Figure 3) and takes account of population structure by matching each 
proband within the DDD cohort to one of four continental populations within the ExAC 
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dataset (Methods). We demonstrated that our method is well-calibrated by showing that the 
number of biallelic rare synonymous genotypes observed in probands closely follows the 
null distribution (Supplementary Figure 4).
We estimated the probability of sampling N probands from unrelated families with the 
observed clinical phenotypic similarity using the sum of the maximum Information Content 
(maxIC) among pairwise comparisons between probands’  HPO terms as a summary metric 
and compared to a null distribution of N probands sampled randomly from among the 4,295 
probands studied here (Methods). We demonstrated that this metric is informative by 
comparing probands sharing protein-altering de novo mutations in the same gene to 
permuted data in which the proband-gene relationship is scrambled (Supplementary Figure 
5).
We integrated the p values obtained from the genotypic and phenotypic assessments 
described above using Fisher’ s method (Table 1, Supplementary Table 2). In effect, these 
analyses are testing each and every gene in the genome we can annotate (N=17,370), under 
two models (biallelic LOF and LOF/functional compound heterozygote), and so we set a 
conservative threshold for genome-wide significance of 1.44e-6 (0.05/17,370/2). At this 
threshold, we identified two genes exceeding genome-wide significance, HACE1 and 
KIAA0586, neither of which had previously been implicated in Mendelian disease in 
humans.
We identified eight individuals in six families with compound heterozygosity for two 
apparent LOF variants (N=7) or a LOF and missense variant (N=1) in KIAA0586 (Figure 2). 
Five out of the six families had a suspected diagnosis of Joubert syndrome (MIM 213300) 
with a typical molar tooth sign on brain MR images present in all but one of the affected 
individuals. Ataxia, hypotonia and Duane anomaly were reported features in several of the 
affected individuals (Supplementary Table 3).
KIAA0586 encodes TALPID3, which is a centrosomal protein required for ciliogenesis and 
sonic hedgehog signaling 15. Other genes associated with Joubert syndrome are similarly 
critical for cilia function 16. Mouse homozygous for a null mutation in the gene encoding 
Talpid3 lack cilia and are embryonic lethal, dying during organogenesis with randomized 
left-right patterning; typical characteristics of a ciliopathy 17. All patients were compound 
heterozygous, sharing the same LOF variant, p.(Arg143Lysfs*4). This variant was observed 
at a MAF of 0.4% (383/96534) in ExAC, more frequent than the cumulative MAF of other 
LOF variants in KIAA0586. Therefore we hypothesise that homozygosity for this allele is 
likely embryonic lethal and that our patients are compound heterozygous for a null allele 
and a hypomorphic allele.
We identified three individuals from three families with biallelic rare LOF variants in 
HACE1, and an additional family with a homozygous inframe deletion of a single codon in 
three affected siblings (Figure 3). These variants were associated with intellectual disability 
and significant abnormality in resting muscle tone; five of the six affected individuals had a 
combination of hypotonia, dystonia and spasticity. Only one (281381) of the six affected 
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individuals was ambulant (Supplementary Table 3). Brain MR images show brain atrophy 
and variable hypoplasia of the corpus callosum (Figure 3)
HACE1 encodes a HECT domain containing E3 ubiquitin ligase, expressed in brain. 
Notably other brain expressed HECT domain E3 ubiquitin ligases have also been associated 
with intellectual disability 18. HACE1 regulates Rac1, a small GTPase with diverse roles in 
signaling. A homozygous knock-out mouse model of HACE1 has been described 19 which 
has almost complete pre-weaning lethality, of unknown mechanism.
We also identified four genes (MMP21, PRMT7, CSTB and COL9A3) with suggestive 
initial evidence (p<1e-4) but not meeting genome-wide significance (Table 1), two of which 
were previously implicated recessive causes of DDs (CSTB and COL9A3). We further 
evaluated MMP21 and PRMT7 with co-segregation studies, deeper clinical assessment and 
animal models, and found compelling evidence for recessive causation.
We identified two individuals and one fetus from two families compound heterozygous for 
different LOF and missense variants in MMP21, which encodes a matrix metalloproteinase 
(Figure 4). Both affected individuals and the affected fetus presented with visceral 
heterotaxy (situs ambiguous; MIM 306955), including complex heart malformations. The 
missense mutations lie in close proximity in the conserved zinc-binding site, both predicted 
to have a major impact on enzymatic activity (Figure 4). Biallelic damaging variants in 
MMP21 have been identified in heterotaxy patients in an independent study (Chris Gordon 
pers comm).
MMP21 has been suggested to function during embryogenesis, and as a matrix 
metalloproteinase, may modulate cell proliferation and migration through regulating 
extracellular matrix remodeling 20. Two heterotaxy mutant mouse models, Miri and Koli, 
were recovered from a phenotype-based mutagenesis screen with pathogenic Mmp21 
missense mutations in the zinc binding domain (Figure 4). Mutants exhibit visceral 
heterotaxy with heart defects commonly associated with heterotaxy (Figure 4). While 
heterotaxy can arise from motile cilia defects, videomicroscopy of the embryonic node 
showed normal cilia motility (Supplementary Movie), suggesting Mmp21 acts downstream 
of motile cilia.
We identified six affected individuals from three families with compound heterozygous 
LOF/LOF or LOF/functional variants in PRMT7. The associated clinical phenotype is a 
phenocopy of pseudohypoparathyroidism [PHP; MIM 103580, also known as Albright 
Hereditary Osteodystrophy, AHO]. Mild intellectual disability with obesity and symmetrical 
shortening of the digits and posterior metacarpals and metatarsals were observed, similar to 
the acrodysostosis seen in PHP (Figure 5). Two families shared the same variant at the last 
base of the first coding exon, which may induce aberrant splicing rather than a missense 
change (Arg32Thr). PRMT7 encodes an arginine methyltransferase with several histone 
substrates 21. Protein modeling indicates that all the observed missense variants are likely to 
be damaging (Figure 5, Supplementary Figure 6). Shortly after birth (at P10), PRMT7 
knock-out mice display significantly reduced body size, reduced weight (-48%), and 
shortened 5th metatarsal (Supplementary Figure 7). These mice are subviable with only 
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about 45% the expected number of Prmt7tm1a/tm1a pups found at P14. The surviving adult 
Prmt7tm1a/tm1a mice exhibit increased fat mass, reduced length and limb bone anomalies, 
concordant with the human phenotypes. In addition, reduced bone mineral content and 
density was observed in Prmt7tm1a/tm1a mice, and early onset osteoporosis is observed in 
AHO. All six affected individuals are female and notably the mouse model exhibits 
markedly sexually dimorphic phenotypes including bone mineral content, density and 5th 
metacarpal length changes only significant in females (Figure 5 and Supplementary Table 4). 
Moreover, a strong female bias has been observed in other AHO-like disorders22,23.
Discovering rare autosomal recessive disorders is challenging, especially for genetically 
heterogeneous disorders in outbred populations with small families. Only a small fraction of 
the predicted >1,000 autosomal recessive intellectual disability disorders have yet been 
discovered 24. New strategies for discovering novel recessive disorders are required. We 
have proposed the combined use of large-scale ascertainment of small families with diverse 
clinical presentations, exome sequencing and integrated probabilistic analysis of genotypic 
enrichment and phenotypic similarity. Integrating genotype and phenotype matching 
increased power to detect novel recessive disorders while not overly penalizing discovery of 
new disorders that result in variable or nonspecific clinical presentations (e.g. HACE1). 
Most (10/19) of the families we described here with one of the six recessive disorders shown 
in Table 1 had a single affected child, nonetheless, these families were enriched for affected 
siblings compared to the entire cohort (p=6.3e-5, Poisson test), suggesting that including 
families with affected siblings within our cohort boosts power to detect recessive disorders.
Our method for identifying novel recessive disorders requires systematic genotype and 
phenotype data on a known number of families, and cannot be applied when collating only 
partial genotypic or phenotypic data on selected families. Phenotypic diversity among 
families is fundamental for estimating the significance of phenotypic similarity for a given 
candidate gene. The power of this approach is maximal when recording of phenotype terms 
is complete and consistent. For example, the statistical significance of phenotypic similarity 
for PRMT7 (Table 1) is based on the initial HPO terms associated with individual 270360, 
which did not include annotation of the hand anomalies (Figure 5). Adding the HPO term 
‘ short metacarpal’  post-hoc increases the significance of the phenotypic similarity p value 
considerably from 1.49E-03 to 7.00E-05, and consequently the combined genotypic and 
phenotypic p value for PRMT7 becomes genome-wide significant (p=1.97E-07). Unbiased 
clinical re-evaluation of probands sharing the same candidate gene will likely remain 
valuable.
Recruiting clinicians also recorded whether affected individuals were reminiscent of a 
recognized genetic syndrome, and for three of the recessive disorders described above, the 
same suspected syndrome was annotated recurrently (KIAA0586 – Joubert; COL9A3 – 
Stickler; PRMT7 – Albrights Hereditary Osteodystropy). The statistical significance 
(Methods) of shared syndrome annotation (KIAA0586 – 1e-5 ; COL9A3 – 4.2e-4; PRMT7 – 
8.2e-4) was greater than for HPO phenotype similarity (Table 1), suggesting that 
computational phenotype analysis does not yet capture all of the ‘ gestalt’  information 
utilized by experienced clinicians.
Akawi et al. Page 6
Nat Genet. Author manuscript; available in PMC 2018 June 05.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
Mouse mutants provided additional support for all four novel recessive disorders described 
above. In principle, similarity between HPO terms and mouse mutant phenotypes 25 could 
be incorporated into combinatorial genotypic and phenotypic significance testing 26. 
However, the current lack of consistent phenotyping data on all mouse mutants and the 
incomplete and biased gene coverage of mouse mutants could lead to significant biases.
Comprehensive discovery of all autosomal recessive causes of DDs will require much larger 
datasets. Inevitably this will necessitate international collaboration and harmonizing of 
phenotypic data. The adoption of standard, interoperable phenotype ontologies, such as 
HPO, and, crucially, ensuring they are applied consistently, will be essential.
Online Methods
Families
4,295 patients with severe, undiagnosed, developmental disorders and their parents (4,125 
families) were recruited and systematically phenotyped at 24 clinical genetics centres within 
the UK National Health Service and the Republic of Ireland. The study has UK Research 
Ethics Committee approval (10/H0305/83, granted by the Cambridge South REC, and GEN/
284/12 granted by the Republic of Ireland REC). Families gave informed consent for 
participation and specific additional consent for publication of photographs was sought and 
given by a subset of families.
Clinical data (growth measurements, family history, developmental milestones, etc.) are 
collected using a standard restricted-term questionnaire within DECIPHER, and detailed 
developmental phenotypes for the proband are entered using the Human Phenotype 
Ontology 5.
Exome sequencing
Genomic DNA (approximately 1 µg) was fragmented to an average size of 150 bp and 
subjected to DNA library creation using established Illumina paired-end protocols. Adapter-
ligated libraries were amplified and indexed via PCR. A portion of each library was used to 
create an equimolar pool comprising 8 indexed libraries. Each pool was hybridised to 
SureSelect RNA baits (6541 samples with Agilent Human All Exon V3 Plus with custom 
ELID # C0338371, and 5903 samples with Agilent Human All Exon V5 Plus) with custom 
ELID # C0338371) and sequence targets were captured and amplified in accordance with 
manufacturer’ s recommendations. Enriched libraries were subjected to 75 base paired-end 
sequencing (Illumina HiSeq) following manufacturer’ s instructions.
Mapping of the short read sequences for each sequencing lanelet was carried out using the 
BWA (version 0.59) 27 backtrack algorithm with the GRCh37 1000 Genomes phase II 
reference (also known as hs37d5). PCR and optically duplicated reads were marked using 
Picard (version 1.98) MarkDuplicates. Lanelets were spatially filtered to account for bubble 
artifacts and quality controlled (passing thresholds on percentage of reads mapped; 
percentage of duplicate reads marked; various statistics measuring INDEL distribution 
against read cycle and an insert size overlap percentage). Lanelets were then merged into 
BAMs corresponding to sample’ s libraries and duplicates were marked again with Picard 
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after which they were then merged into BAMs for each sample. Finally sample level bam 
improvement was carried out using GATK (version 3.1.1) 28 and samtools (version 0.1.19) 
29. This consisted of re-alignment of reads around known and discovered INDELs followed 
by base quality score recalibration (BQSR) both using the GATK, lastly samtools calmd was 
applied and indexes were created. Known INDELs for realignment were taken from Mills 
Devine and 1000G Gold set and the 1000G phase low coverage set both part of the Broad’ s 
GATK resource bundle version 2.2. Known variants for BQSR were taken from dbSNP 137 
also part of the Broad’ s resource bundle. Finally, SNV and INDELs were called using 
GATK HaplotypeCaller (version 3.2.2), this was run in multisample calling mode using the 
complete dataset. GATK Variant Quality Score Recalibration (VQSR) was then computed 
on the whole dataset and applied to the individual sample variant calling format (VCF) files.
Annotation of functional consequence
Minor Allele Frequency—To define the rarity of each SNV and INDEL, the VCF is 
annotated with minor allele frequency (MAF) data from a variety of different sources. The 
MAF annotations used include data from 4 different populations of the 1000 Genomes 
project 30 [AMR, ASN, AFR & EUR], the UK10K cohort, the NHLBI GO Exome 
Sequencing Project (ESP) and an internal DDD allele frequency generated using unaffected 
parents. For allele matching of SNVs we use an exact match based on a key generated from 
four values (chromosome, position, reference allele and alternative allele). For allele 
matching of INDELS we use a less stringent approach where the key is constructed using a 
different four values (chromosome, position, slice and direction). This key requires both 
INDELs to be at the same locus (chromosome and position) while the slice is computed 
based on the DNA sequence difference between the reference and alternative alleles and 
direction is either deletion or insertion.
Variant Effect Predictor—To define the functional consequence of each variant (SNVs, 
INDELs and CNVs) annotations from the Ensembl variant effect predictor (VEP) 31 based 
on Ensembl gene build 76 are added to the VCF file. VEP produces a number of annotations 
including, SIFT and Polyphen predictions, ensembl transcripts, HGNC gene names and a 
prediction of the functional consequence for each variant. The transcript with the most 
severe consequence is selected and all associated VEP annotations are based on the effect 
that the variant has on that particular transcript.
We categorised variants into two classes of variation from the VEP consequence predictions:
• Loss of function (LoF): transcript_ablation, splice_donor_variant, 
splice_acceptor_variant, stop_gained, frameshift_variant
• Functional: stop_lost, initiator_codon_variant, transcript_amplification, 
inframe_insertion, inframe_deletion, missense_variant, coding_sequence_variant
In addition to the standard VEP-predicted consequences, we expanded the definition of 
splice donor variants to include those at the neighbouring last base of coding exons, if it is 
guanine in the reference sequence, as these are highly conserved within the position weight 
matrix of splice donor sites 32 and exhibits a skew towards rare variants – a characteristic 
signature of functional impact – that in unaffected DDD parents is more akin to canonical 
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splice donor sites than missense variants (Supplementary Figure 1). We identified bases in 
the human genome at the 3’  end of exons, where the base at that site was a guanine (specific 
to the strand of the transcript). Exon coordinates were obtained from GENCODE release 19 
33, and sequence at these positions were extracted from the hs37d5 reference assembly 30. 
We only included sites which overlapped synonymous or missense variants to exclude sites 
outside of the coding sequence.
Mendelian filtering
Of the 4,125 families recruited to the DDD study, we excluded 1,053 families from 
downstream recessive analyses on the basis of having de novo mutations predicted to alter 
the coding sequence of genes already robustly linked to dominant or X-linked developmental 
disorders. For the remaining families, we identified rare (maximum minor allele frequency 
less than 1%), protein-altering variants in the probands that were consistent with a recessive 
mode of inheritance. The remaining variants were either compound heterozygous variants or 
homozygous non-reference variants, averaging 3.2 variants per proband.
The numbers of probands in each of the functional categories (biallelic LoF, or compound 
heterozygous LoF/functional) were tallied for each gene. For families with affected siblings 
found to share rare recessive genetic variants within a gene, only the eldest sibling was 
included in the tally, in order to have counts from independent families.
The variant filtering was conducted in python, this analysis used version 0.2.0.
Statistical genotypic assessment
We tested all genes (coordinates from GENCODE release 19) for enrichment of rare (minor 
allele frequency < 1%), recessive LoF and functional (see above) genotypes in unrelated 
families. Because allele frequency can vary by population, and this affects the probability of 
randomly observing recessive genotypes, we calculated the cumulative frequency of rare 
alleles in each gene from the ExAC dataset version 0.3 (accessed 2015-02) in four ancestral 
populations: European (excluding Finns) - NFE; African - AFR; East Asian - EAS and 
South Asian - SAS. Different alternate alleles at multiallelic sites were examined separately, 
using the most severe consequence relating to each allele. We classified each undiagnosed 
DDD proband into one of these four ancestral populations by projecting them onto a 
principal component analysis of 1000 Genomes populations (using SNPRelate): AFR 
(N=109), EAS (N=15), NFE (N=2799) and SAS (N=297).
Because rare recessive genotypes are much more likely to be observed in autozygous 
segments (inheriting DNA from a recent common ancestor from both parents, e.g. in the 
case of consanguinity), we used bcftools roh (version 1.0) to call autozygous segments 
across the entire exome, and determined the number of probands autozygous across each 
gene of interest. We then adjusted the probability of sampling two rare LoF alleles for the 
number of probands autozygous across each gene.
The probability of drawing N unrelated families with recessive genotypes in the same gene 
by chance was estimated as the binomial probability (including autozygosity) of sampling 
two rare alleles of a specified functional category N or more times from random draws 
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matched to our ancestral populations (i.e. 109 AFR, 15 EAS, 2799 NFE, 297 SAS). We 
determined the entire set of combinations by which N or more families could be distributed 
across the four ancestral populations, and the probability of observing each combination 
using population-specific frequencies. We summed these probabilities across all possible 
combinations to obtain an aggregate probability for sampling N or more families by chance.
An R package was developed to perform these statistical analyses, this analysis used version 
0.5.0.
Statistical phenotypic assessment
HPO phenotype similarity—Clinical geneticists referring each proband into the DDD 
study systematically recorded phenotypes using the Human Phenotype Ontology (HPO) 5. 
These terms were used to assess the probability that probands sharing the same candidate 
recessive share more similar clinical phenotypes than expected by chance. Similarity testing 
used the Human Phenotype Ontology version 2013-11-30.
The similarity of HPO terms between two individuals was estimated as the maximum 
information content (maxIC) from pairwise comparisons of the HPO terms for the two 
individuals. For each pairwise comparison of two HPO terms we determined the information 
content for the most informative common ancestor of the two terms. The information 
content is calculated as the negative logarithm of the probability of the terms’  usage (or any 
of its descendant terms) within the population of all 4,295 probands in the DDD study.
The summary phenotype similarity score for a set of N probands was estimated as the sum 
of all the pairwise maxIC scores. The null distribution of this summary phenotype similarity 
score was simulated by randomly sampling sets of N probands and calculating summary 
scores as above. The p-value was calculated as the proportion of simulated scores greater 
than or equal to the observed score.
We demonstrated that this summary phenotype similarity score is both informative and well-
calibrated by comparing probands sharing protein-altering de novo mutations in the same 
gene to permuted data in which the proband-gene relationship is scrambled (Supplementary 
Figure 5). The permuted data closely follows the expected null distribution.
These analyses were conducted in Python, this analysis used version 0.3.1.
Suspected syndrome similarity—In addition to HPO annotation, recruiting clinicians 
also annotated whether affected individuals were reminiscent of a recognized 
phenotypically-defined syndrome. These suspected syndrome annotations were initially 
standardised to correct, for example, misspellings and abbreviated syndrome names.
The similarity of suspected syndrome terms between two probands was calculated as the 
negative logarithm of the observed probability of selecting the rarest matched syndrome 
term between the probands. The observed probability of selecting each term was calculated 
as the frequency with which the term was used in the probands with at least one suspected 
syndrome. We compared the similarity of the probands for each candidate recessive gene to 
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a null distribution constructed by simulating 100000 permutations of randomly sampling 
probands from the set of probands with at least one suspected syndrome.
Combining genotype-phenotype assessment p values
For each gene, we integrated the p-values obtained from the genotypic and phenotypic 
assessments described above using Fisher’ s method. For the genotypic tests, we had 
performed tests for two models (biallelic LoF and LoF/functional compound heterozygote). 
We selected the more significant genotypic test for each gene, since some genes had only 
biallelic LoF probands, while other genes only had LoF/missense compound heterozygotes. 
These analyses effectively are testing each and every gene in the genome, under the two 
models, and so we set a conservative threshold for declaring genome-wide significance of 
1.44 x 10-6 (0.05/(17,370*2)).
Code availability
Software for variant filtering analyses available at: https://github.com/jeremymcrae/clinical-
filter, this analysis used version 0.2.0.
Software for HPO phenotype similarity analyses available at: https://github.com/
jeremymcrae/hpo_similarity, this analysis used version 0.3.1.
Software for recessive genotype enrichment analyses available at: https://github.com/
jeremymcrae/recessiveStats, this analysis used version 0.5.0.
Protein modeling
Identification of template protein structures—Protein structures having high 
sequence homology with the protein to be modelled found by using the sequence similarity 
search tool at the Protein Data Bank in Europe. Where no hits with a high sequence 
homology were found, only the relevant domains were used for searching and the sequences 
of the matches recorded. For modeling PRMT7, a mouse structure with high sequence 
identity was found for the whole sequence (PDB ID: 4C4A). For MMP21 and HACE1 
HECT domain, multiple template sequences were selected for modeling since the sequence 
identity was borderline for modeling (~30-40%).
Structure Modeling—The Swiss-Model server was used to model the protein structure 
based on sequence templates chosen in the previous step. The models were downloaded and 
where multiple template sequence were used, these were superposed using PDBeFold 
service so as to be on the same coordinate reference for comparison. If the fold of the 
multiple models were the same, only the model with highest sequence homology was used 
for further analysis (MMP21: Model built on PDB ID: 1y93; HACE1 HECT Domain: 3tug). 
Models were built for both the mutated and non-mutated sequence for comparison and 
validation in the next step.
Mutation Modeling—Mutations were introduced in the modelling programme Chimera 
34 and the best rotamer for the new amino acid based on inspection of conformational space 
around the mutation. The overall structure was optimised using the energy minimize 
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function in Chimera with 100 cycles of steepest descent and 100 cycles of conjugate 
gradient energy minimisation. The energy minimised models of the mutated structures were 
compared with the models built for the mutated sequence in the previous step to validate the 
modelling strategy.
Model Assessment—Model assessments were done by comparison of the non-mutated 
and mutated structures in PyMol (The PyMOL Molecular Graphics System, Version 1.7.4 
Schrödinger, LLC.). All figures of the structure models were also made using PyMol
Mouse modeling of Mmp21
Mouse Mutagenesis Screen and Recovery of Mmp21 Mutants—Miri (B2b873) 
and Koli (b2b2458) mutant lines were recovered from a large-scale recessive mouse N-ethyl-
N-nitrosourea mutagenesis screen conducted in C57BL6/J mice. Fetal echocardiography was 
used to identify mutants with congenital heart disease (CHD)35,36. Fetuses diagnosed with 
congenital heart defects were further analyzed by necropsy and imaging using micro 
computed tomography and/or episcopic confocal microscopy was conducted for detailed 
histopathological examination of intracardiac anatomy for CHD diagnosis37. This study was 
approved by the Institutional Animal Care and Use Committee of the University of 
Pittsburgh and conforms to NIH guidelines.
Whole Exome Sequencing and Mutation Recovery of Mmp21 Mutations—
Genomic DNA from a Miri and Koli mutant were analyzed by whole mouse exome 
sequencing analysis using Agilent SureSelect Mouse All Exon Kit V1, followed by Illumina 
HiSeq 2000 sequencing to achieve a minimum of 50X average target sequence coverage 
(conducted by BGI Americas). Sequence reads were aligned to the C57BL6 reference 
genome (mm9) and analysis was carried out using CLCBio Genomic Workbench and GATK 
software. All variants were annotated with annovar and filtered against dbSNP128 and in-
house mouse exome databases with custom scripts. Homozygous coding variants recovered 
from each mutant line were genotyped across all mutants, with the pathogenic mutation 
identified as the single mutation consistently homozygous in all mutants. Thus the Miri line 
was shown to harbor a Mmp21 W177L pathogenic mutation, while Mmp21 Y325N 
pathogenic mutation was identified in the Koli mutant line. Further breeding of both lines 
across multiple generations has confirmed the Mmp21W177L and Mmp21Y325N mutations as 
the pathogenic mutations causing heterotaxy and complex CHD in the Miri and Koli mutant 
lines, respectively.
Nodal Cilia Videomicroscopy—The embryonic node from E7.75 embryos was 
dissected for analysis of cilia motility with 0.35µm microspheres (Polysciences) added to 
assess flow. Imaging was conducted using a Leica DMIRE2 inverted microscope equipped 
with a 100x oil objective and differential interference contrast optics. High-speed videos 
were collected at 200 fps using a Phantom v4.2 camera (Vision Research).
Mouse modeling of Prmt7
Mice homozygous for the Prmt7tm1a(EUCOMM)Wtsi allele (hereafter referred to as 
Prmt7tm1a/tm1a) was generated as part of the European Conditional Mouse Mutagenesis 
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Program and Knockout Mouse Project (EUCOMM/KOMP) projects and Sanger Mouse 
Genetics Project 38. Mice were generated from embryonic stem cell clone EPD0070_4_F09 
and JM8.N4 ES cell line and maintained on a C57BL/6N;C57BL/6-Tyrc-Brd. Genotyping 
was carried out as previously described 39. Animals were housed in specific pathogen-free 
conditions and placed on a Western high fat diet (Special Diet Services, Witham, UK) from 
4 weeks of age with ad libitum access to autoclaved, nonacidified water and food and 
phenotyped according to a previously reported standard pipeline, including Dual-energy X-
ray absorptiometry and high-resolution X-ray imaging 40. Bone lengths were derived from 
the original DICOM files of the left forearm and paw using Sante DICOM Editor 4 program 
(Santesoft, Athens, Greece). All experiments were performed in accordance with the UK 
Home Office regulations, UK Animals (Scientific Procedures) Act 1986. Adult phenotyping 
was performed blind to genotype groups, with a minimum of 7 animals per group.
Prmt7tm1a/tm1a mouse data was analysed using RStudio running R version 3.1.2 and Phenstat 
package version 2.0.1. This uses a mixed-model framework as described 41 to assess the 
impact of genotype on phenotype. The analysis was performed by loading mouse body 
weight into the starting model: Y= Genotype+ Sex+ Genotype*Sex +Weight. Multiple 
correction testing was performed on the global p-value using the Hochberg correction.
For mouse skeletal staining, mice were killed by lethal IP injection of anesthetic at P10 and 
confirmation of death was performed by cutting of the femoral artery. Skin and inner organs 
were removed and full skeletons were first fixed with 100% EtOH for 2 days and then 
placed in Alcian blue to stain proteoglycans for 24 hours. Then shortly washed with EtOH to 
remove rest of Alcian blue and cleared in 1%KOH for 24 hours. Skeletons were then placed 
in Alizarin red staining solution, to detect calcium deposits for at 24 hours and then again in 
1%KOH. Skeletons were then embedded in 100% Glycerol, after ascending series of KOH-
glycerol mixture (1%KOH:Gly v/v: 80:20, 60:40, 40:60, 20:80). Pictures were acquired with 
a Leica stereomicroscope and Leica Application System (LAS V4) and bones were 
measured with Image J. For statistical analysis the Wilcoxon test was performed with R 
Studio (version 0.98.501)
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Overview of analytical strategy
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Figure 2. Clinical and neuroradiological features associated with biallelic variants in KIAA0586
A. Family structures, genotypes and phenotype key of the six families of the affected 
individuals with biallelic mutations in KIAA0586. The DECIPHER ID is given above and to 
the left of the pedigree symbol for each affected individual recruited to the DDD study. NT 
indicates an unaffected individual who has not been tested from the family mutations in 
KIAA0586. Where available an anterio-posterior (AP) facial photographs and a transverse 
section from the brain MR is given below the family tree. The white dashed box and white 
lines indicate the expanded region of the same image illustrating the “molar tooth” shape of 
the brainstem that is considered characteristic of Joubert syndrome in Families 1, 2, 4 and 5. 
In family 6 the brainstem shape is atypical for Joubert syndrome. The DECIPHER ID is 
indicated in all images. Informed consent was obtained to publish photographs. B. A cartoon 
depicting the protein domain structure of KIAA0586 (1533 aa) encompassing TALPID3 
chain (100-1,343; in blue), which includes a highly conserved Region (467 – 554 aa; in 
orange) required for centrosomal localization and two coiled-coil (182-232 & 467-501 aa; in 
yellow) domains. A red asterix (coding region variant) or dashed line (essential splice site) is 
used to indicate the position of each pathogenic mutations identified in the families above.
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Figure 3. Clinical and neuroradiological features associated with biallelic variants in HACE1
A. Family structures and genotypes of four families. The DECIPHER ID is given for each 
recruited affected individual. NT indicates an individual who has not been tested from the 
family mutations in HACE1. Where available an anterio-posterior (AP) facial photographs 
and a transverse section from the brain MR is given below the family tree. The elder sibling 
in Family 4 is also recruited to DDD but on recruitment was considered to have a different 
disorder from his brother, primary microcephaly. Where available photographs of the face, 
hands and feet are presented. Saggital and transverse sections from the brain MR is given 
below the family tree. The saggital images show hypoplasia of the corpus callosum and the 
transverse images show an apparently reduced brain volume due to paucity of white matter. 
Informed consent was obtained to publish photographs.
B. Protein domain structure of HACE1 (909 aa) encompassing 6 Ankyrin repeats (in orange) 
and 1 HECT (E6AP-type E3 ubiquitin-protein ligase) domain (574 – 909 aa; in blue). A red 
asterix indicates the position of each pathogenic mutation.
C. Prediction of mutation consequence on tertiary protein structure based on PDB IDs: 4bbn 
and 3tug. The HECT domain is highly conserved and all models share the same fold. The 
deletion of Leu 832 has significant effect on the fold of the protein. This mutation disrupts 
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the helix by perturbing the hydrophobic core of the domain. This suggests that the mutated 
protein (ΔLeu832) is unlikely to have the same fold.
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Figure 4. Features associated with biallelic variants in MMP21/Mmp21 in humans and mice
A. Pedigrees and genotypes of two families, with DECIPHER IDs. Photograph showing 
mild craniofacial dysmorphisms including hypoplasia of the malar region and supraorbital 
ridges and prominent lips. Informed consent was obtained to publish the photograph.
B. Modeling of the effect of variants on the tertiary structure of MMP21, based on PDB IDs 
1Y93 and 1FBL. Wildtype and mutated residues shown in cyan. The His283Tyr mutation 
severely reduces Zn2+ binding. The Ile285Thr mutation causes loss of hydrophobicity and 
weaker interactions with neighbouring non-polar amino acids (green) and should cause 
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movements of surrounding residues potentially leading to conformational shifts that affect 
Zn2+ binding.
C. Protein structure (569aa) encompassing signal peptide (1-24 aa; in orange), propeptide 
(25- 144 aa; in grey) and matrix metalloproteinase-21 chain (145 – 569 aa; in blue) that 
includes 4 Hemopexin repeats, with the positions of the human mutations shown above, and 
positions of ENU-induced mutations in mice shown below.
D. Necropsy picture of a Miri mutant with dextrocardia with anterior positioning of the aorta 
(Ao), indicating transposition of the great arteries (TGA), right lung isomerism, inverted 
liver lobation (1-3), and dextrogastria (Stm). Confocal episcopic microscopy showed: Miri 
mutant exhibiting dextrocardia with TGA (E) and atrioventricular septal defect (AVSD) (F), 
Koli mutant with double outlet right ventricle (G), Miri mutant with dextrocardia with TGA 
and hypoplastic right ventricle (H), mutant with anomalous right subclavian artery from 
pulmonary trunk (I), and mutant with duplicated inferior vena cava (IVC) draining into 
bilaterally symmetric right atria, indicating right atrial isomerism (J).
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Figure 5. Features associated with biallelic variants in PRMT7/Prmt7 in humans and mice
A. Pedigrees and genotypes of three families. The DECIPHER ID is given for each recruited 
affected individual. The father in Family 3 had a cleft lip which is thought to be coincidental. 
AP facial photographs of the affected individuals are given below the pedigrees. In Family 2 
and 3 pictures of the foot show shortened posterior metatarsals. In Family 3 a photo of the 
hand of an affected individual shows brachydactyly with short metacarpals. Informed 
consent was obtained to publish photographs.
B. Protein domain structure of PRMT7 (692 aa) encompassing two active S-
adenosylmethionine-dependent methyltransferases (SAM or AdoMet-MTase) PRMT-type 
domains (14 – 345 aa; in blue & 358 – 684 aa; in orange). Red asterixes indicate the 
positions of pathogenic mutations.
C. Data derived from mice homozygous for a targeted inactivation of Prmt7 (null; 
Prmt7tm1a/tm1a). DEXA scanning at 14 weeks of age indicates: female null mice have a 
reduced bone mineral content (top left graph), both male and female null mice have elevated 
fat mass (as a percentage of total body mass; top right graph) and reduced body length as 
determined by distance from nose to the base of the tail (bottom right graph). X-Ray images 
from 14 week old mice show that the length of the 5th metacarpal was reduced in female null 
mice only. Box-and-whiskers plots show min-mean-max values. P-values presented are 
either global adjusted p-values for genotype, or (for sexual dimorphism) the p-value for the 
interaction between sex and genotype.
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Table 1
Integrated genotype-enrichment and phenotype-matching: genes with combined p-value less than 1e-4
Gene # LOF/
LOFa
#LOF/
Funcb
P(geno)c P(pheno)d Combinede Evidence Additional evidence
KIAA0586 6 1 1.42E-06 5.60E-04 1.75E-08 Genome-wide significant Co-segregation in two affected sibs
Mouse and chick mutants with ciliary phenotypes
HACE1 3 0 2.39E-08 1.11E-01 5.50E-08 Genome-wide significant Co-segregation in one affected sib
Three affected sibs with homozygous inframe deletion
Mouse mutant with early lethality phenotype
PRMT7 1 2 1.45E-04 1.49E-03 3.53E-06 Suggestive Co-segregation in three affected sibs
Concordant mouse mutant with AHO-like phenotype
CSTB 2 0 3.16E-05 1.76E-02 8.56E-06 Suggestive Previously implicated gene
COL9A3 2 0 3.89E-05 4.08E-02 2.28E-05 Suggestive Previously implicated gene
MMP21 0 2 2.05E-03 1.03E-03 2.97E-05 Suggestive Co-segregation with affected sib
Two mouse mutants with heterotaxy
aNumber of families with biallelic LOF variants
bNumber of families compound heterozygous for LOF and functional variants
c
Binomial p value of sampling N families, minimum of LOF/LOF and LOF/functional tests
d
Phenotype matching p value assessed by permutation
eGenotype and Phenotype p values combined using Fisher’ s methods
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